Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF? - Wikidata - awgldk - TriplyDB

Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

http://www.wikidata.org/entity/Q38817707

about

Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

http://www.wikidata.org/entity/Q38817707

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

@en

type

label

Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

@en

prefLabel

Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

@en

P1433

Q38817707-33DA43AF-7619-453B-B77B-052658A40B28

P1476

Q38817707-E907FF88-229A-4120-9F67-EA69EF39735A

P2093

Q38817707-A0C4BC19-072A-422F-A9E1-5138A448295E

P2860

Q38817707-092E5089-A265-4D5C-871F-752F7172AECA

Q38817707-0D6AB78C-224A-4D31-BEB3-200CADB6607C

Q38817707-1A548818-8835-4CBA-9027-A9B0400AF9AB

Q38817707-1AF3B932-5EC4-49F2-98CD-DF00556D3895

Q38817707-1C13D803-285C-43E9-B6F1-29552E60DDE8

Q38817707-389AC414-17C1-44F7-9C44-A5EDA7E7E00A

Q38817707-38B3D340-28AD-4300-BE24-BB106AA4CDE2

Q38817707-3BD78295-6F4C-4C1A-9564-DCB72BD84F05

Q38817707-3C5CB5EF-1157-4DD1-A0EC-14614A0559AE

Q38817707-414BBFEA-4F7A-4AF0-821B-59AFD389CF03

P2888

Q38817707-650481E5-8255-4830-890B-08C659352F0F

P304

Q38817707-A65ED45F-8F76-4AF2-8E72-0B092F8C4233

P31

Q38817707-17EA7843-B995-45D5-80A0-D17F969B9E16

P356

Q38817707-7801A6F8-7E6C-4749-BFD2-AA1E96F05367

P433

Q38817707-ED27AE3B-A78C-493B-9941-9C583C5C9656

P478

Q38817707-1B033932-6E50-40A7-B727-AA03C910F496

P50

Q38817707-F33E5278-F068-4545-AAC5-0B27BC7934C6

P577

Q38817707-CE13DC83-5D09-46CD-8391-297D851EE03D

P698

Q38817707-0061FC25-EEDB-498A-BBBF-CDAB7E9BCFF2

P356

S11936-017-0537-3

P1433

Current treatment options in cardiovascular medicine

P1476

Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

@en

P2093

Atul Verma

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Epidemiology and natural history of atrial fibrillation: clinical implications.

A comparison of rate control and rhythm control in patients with atrial fibrillation.

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

Electrical, contractile and structural remodeling during atrial fibrillation.

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

P2888

s11936-017-0537-3

P304

38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11936-017-0537-3

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28447320

http://www.w3.org/2001/XMLSchema#string